Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Promoting Enhanced Pharmacotherapy Choice Through Immunomarkers Evaluation in Depression

NCT03993457 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.

NCT NCT03993457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03993457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Promoting Enhanced Pharmacotherapy Choice Through Immunomarkers Evaluation in Depression
Lead sponsor
University of Texas Southwestern Medical Center
Phase
Phase 4
Overall status
Terminated
Start date
July 23, 2019
Completion date
March 25, 2022
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression